Discount contracts for medicines with the active substance dexamethasone, implants only

Summary

The tender concerns non-exclusive discount contracts for medicines containing the active substance dexamethasone, intended for implants only. The contract is conducted under an open-house model and runs from 01 November 2026 to 31 October 2028, with the possibility to conclude contracts at any time during the period. In the Open House procedure, medicines intended for pediatric use are excluded under § 35 Abs. 5a SGB V.